Clinical Trial Update: Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluated melphalan hydrochloride in patients with newly diagnosed multiple myeloma undergoing donor stem cell transplantation,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• MELPHALAN HYDROCHLORIDE (MELPHALAN HYDROCHLORIDE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Plasma Cell Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-01